Back to results
US 2014/0370030 A1Published application
Antibodies anti-spla2-x and uses thereof
AssigneesCentre National de la Recherche Scientifique (CNRS), Universite Nice Sophia Antipolis
InventorsGerard Lambeau, Emmanuel Valentin, Melanie Rennou
Life of this patent
Estimating the term…
Abstract
The present invention relates to isolated antibodies against human sPLA2-X and uses thereof.
Claims17
-16. (canceled)
An isolated antibody comprising a variable region of a heavy chain and a variable region of a light chain, wherein said antibody has a Kd for binding to human sPLA2-X less than 10−9 M.
An expression vector comprising at least one of SEQ ID NO:
- 17, SEQ ID NO:
- 18, SEQ ID NO:
- 19 and SEQ ID NO:
- 20, or any sequence having a nucleic acid sequence that shares at least 60% of identity with SEQ ID NO:
- 17-20.
2 more elements
A hybridoma cell line producing an antibody against human sPLA2-X registered under CNCM I-4523 and/or CNCM I-4524.
Dependencies are inferred from the claim text.